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Background: Evidence suggests that DNA methylation (5mC) is important in the development of 
essential hypertension (EH). The 5mC percentage, a measurement for global methylation studies, in 
peripheral blood leukocytes (PBL) has been previously associated with hypertension. Methylation 
patterns are tissue-specific, contributing to differences in transcriptional regulation and cellular 
differentiation. So far, there have been no studies of 5mC in the kidney – an important effector organ in 
EH. Furthermore, there has been no investigation of the relationship between 5mC patterns in the 
hypertensive kidney and PBLs.  
Aims: (i) To determine if global 5mC in the kidney is correlated to hypertension diagnosis and blood 
pressure (BP) regulation. (ii) To determine whether PBLs provide a surrogate for cross-tissue patterns 
of 5mC in the kidney.   
Methods: We used 96 human kidney and 76 human PBL samples from the TRANSLATE study to 
investigate global 5mC percentage. TRANSLATE consists of carefully characterized collections of 
“apparently healthy” specimens of human kidneys. Global methylation was determined using the 5mC 
ELISA kit (Zymo Research) that measures the total amount of 5mC present in a sample. 
Results: We found no association of global 5mC percentage in kidney (P=0.18) and PBL (P=0.54) with 
hypertension diagnosis, nor between PBL 5mC percentage and BP. However, a negative correlation 
was found between kidney 5mC percentage and systolic BP (r=–0.246; P <0.05), and diastolic BP (r=–
0.319; P <0.01). This association was still evident after adjustment for antihypertensive medication for 
systolic BP (r=–0.210; P <0.05) and diastolic BP (r=–0.273; P <0.01). Furthermore, we found a strong 
positive correlation between normotensive kidneys and leukocyte 5mC percentages (r=0.864; P <0.01). 
Similarly, a strong positive correlation was evident for hypertensive kidneys and leukocyte 5mC 
percentages (r=0.916; P <0.01). 
Conclusion: Our findings show that kidney 5mC, but not PBL 5mC, is correlated to BP regulation. No 
relationship was evident for global 5mC and hypertension diagnosis, regardless of the tissue type 
studied. Furthermore, PBL 5mC global methylation percentage was highly correlated to kidney 5mC 
percentage. These results highlight the importance of further studies on the involvement of kidney DNA 
methylation in hypertension, as well as further investigation of the relationship between methylation 
patterns in the kidney and blood. 
  
